117 related articles for article (PubMed ID: 6495445)
1. Possibilities for an extended classification of bladder cancer.
Wahren B; Nilsson B; Esposti PL; Edsmyr F; Holmberg V
Urol Res; 1984; 12(4):195-7. PubMed ID: 6495445
[TBL] [Abstract][Full Text] [Related]
2. Prediction of survival and recurrence in bladder carcinoma.
Nilsson B; Wahren B; Esposti PL; Edsmyr F
Urol Res; 1982; 10(3):109-13. PubMed ID: 7135696
[TBL] [Abstract][Full Text] [Related]
3. Short-term prognosis of bladder cancer. Evaluation with urinary CEA.
Holmberg V; Nilsson B
Anticancer Res; 1984; 4(3):121-2. PubMed ID: 6465848
[TBL] [Abstract][Full Text] [Related]
4. Urinary CEA for prediction of survival time and recurrence in bladder cancer.
Wahren B; Nilsson B; Zimmerman R
Cancer; 1982 Jul; 50(1):139-45. PubMed ID: 7083117
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a double-monoclonal radioimmunoassay for the measurement of carcinoembryonic antigen in the urine of patients with bladder cancer.
Hetherington JW; Ewing R; Cooper EH
Eur Urol; 1986; 12(4):270-3. PubMed ID: 3743597
[TBL] [Abstract][Full Text] [Related]
6. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
Zimmerman R; Wahren B; Edsmyr F
Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
[TBL] [Abstract][Full Text] [Related]
7. Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
Tailly G; Cornelissen M; Vereecken RL; Verduyn H; Devos P; De Roo M
Br J Urol; 1983 Oct; 55(5):501-7. PubMed ID: 6626896
[TBL] [Abstract][Full Text] [Related]
8. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
James K; Alroy J; Miller AW; Flanagan M
Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
[TBL] [Abstract][Full Text] [Related]
9. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
Korsten CB; Persijn JP; Renaud J
Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
[No Abstract] [Full Text] [Related]
10. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen in serum, urine and cells of patients with bladder carcinoma.
Wahren B; Edsmyr F
Urol Res; 1978; 6(4):221-4. PubMed ID: 369085
[TBL] [Abstract][Full Text] [Related]
13. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay].
Kawano S
Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):469-74. PubMed ID: 2464713
[No Abstract] [Full Text] [Related]
17. A modified assay for measuring human urinary carcinoembryonic antigenic (CEA) activity.
Wu JT; Madsen AC; Bray PF
Biochem Med; 1975 Nov; 14(3):305-16. PubMed ID: 1225331
[No Abstract] [Full Text] [Related]
18. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
Tanaka K; Takashi M; Miyake K; Koshikawa T
Urol Int; 1994; 52(3):140-4. PubMed ID: 8203052
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors in bladder cancer].
Matveev BP; Bogatyrev VN; Ermilova VD; Figurin KM; Mustia AI; Iurasova IV; Ataev AA
Urol Nefrol (Mosk); 1994; (5):43-5. PubMed ID: 7871623
[TBL] [Abstract][Full Text] [Related]
20. Screening tests for detection of bladder cancer.
Betkerur V; Rao R; Hlaing V; Rhee H; Baumgartner G; Guinan P
Urology; 1980 Jul; 16(1):16-9. PubMed ID: 7395005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]